BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33039650)

  • 1. Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease.
    Zitouni K; Steyn MRCP; Lyka E; Kelly FJ; Cook P; Ster IC; Earle KA
    Free Radic Biol Med; 2020 Dec; 161():283-289. PubMed ID: 33039650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT).
    Earle KA; Zitouni K; Pepe J; Karaflou M; Godbold J
    J Transl Med; 2016 Aug; 14(1):234. PubMed ID: 27492324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
    Mosenzon O; Wiviott SD; Cahn A; Rozenberg A; Yanuv I; Goodrich EL; Murphy SA; Heerspink HJL; Zelniker TA; Dwyer JP; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Kato ET; Gause-Nilsson IAM; Fredriksson M; Johansson PA; Langkilde AM; Sabatine MS; Raz I
    Lancet Diabetes Endocrinol; 2019 Aug; 7(8):606-617. PubMed ID: 31196815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes.
    Wong FN; Tan JA; Keng TC; Ng KP; Chua KH; Kuppusamy UR
    Clin Chim Acta; 2016 Jan; 453():56-61. PubMed ID: 26657980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measured glomerular filtration rate (mGFR) before and 6 months after bariatric surgery: A pilot study.
    Clerte M; Wagner S; Carette C; Brodin-Sartorius A; Vilaine É; Alvarez JC; Abe E; Barsamian C; Czernichow S; Massy ZA
    Nephrol Ther; 2017 May; 13(3):160-167. PubMed ID: 28161263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating glomerular filtration rate: Performance of the CKD-EPI equation over time in patients with type 2 diabetes.
    Wood AJ; Churilov L; Perera N; Thomas D; Poon A; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Complications; 2016; 30(1):49-54. PubMed ID: 26597601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
    Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
    J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
    Tofte N; Lindhardt M; Adamova K; Bakker SJL; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Heerspink HJL; Kooy A; Laverman GD; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Petrie JR; Ruggenenti PL; Rutters F; Rychlík I; Siwy J; Spasovski G; Speeckaert M; Trillini M; Zürbig P; von der Leyen H; Rossing P;
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):301-312. PubMed ID: 32135136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
    Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
    J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.
    Liu JJ; Liu S; Gurung RL; Ang K; Tang WE; Sum CF; Tavintharan S; Lim SC
    Nephrol Dial Transplant; 2020 Jan; 35(1):115-121. PubMed ID: 30007296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of dynamic renal resistive index (DRIN) for renal outcome in type 2 diabetes and essential hypertension: a prospective study.
    Bruno RM; Salvati A; Barzacchi M; Raimo K; Taddei S; Ghiadoni L; Solini A
    Cardiovasc Diabetol; 2015 May; 14():63. PubMed ID: 25994303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
    Babaliche P; Nadpara RA; Maldar A
    J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.